MAOB and Parkinson disease: They found that treatment with dopamine agonists may be more effective than treatment with MAO-B inhibitors and COMT inhibitors in managing symptoms of Parkinson’s disease, but regarding dopamine agonists and MAO-B inhibitors, they found no significant differences between individual drugs within each drug class [5].